These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19702986)

  • 21. Warfarin-induced skin necrosis.
    Nazarian RM; Van Cott EM; Zembowicz A; Duncan LM
    J Am Acad Dermatol; 2009 Aug; 61(2):325-32. PubMed ID: 19615543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calciphylaxis in a diabetic patient provoked by warfarin therapy.
    Asobie N; Wong E; Cook MG
    Clin Exp Dermatol; 2008 May; 33(3):342-4. PubMed ID: 18419610
    [No Abstract]   [Full Text] [Related]  

  • 23. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 24. [Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case].
    Marutaka M; Kubota Y; Yoshida R; Orita Y
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1561-3. PubMed ID: 19755834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lingual haematoma: a rare complication of usual warfarin dose.
    Acar F; Girisgin SA; Cander B; Ozdinc S
    Emerg Med J; 2008 Jul; 25(7):406. PubMed ID: 18573949
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 27. Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency.
    Kurt M; Shorbagi A; Aksu S; Haznedaroglu I; Altundag K; Erkin G
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):805-6. PubMed ID: 17982324
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute massive suprachoroidal hemorrhage after photodynamic therapy in a patient treated with warfarin.
    Petropoulos IK; Ekonomidis P; Theoulakis PE; Gatzogias MI; Katsimpris JM
    Klin Monbl Augenheilkd; 2009 Apr; 226(4):365-7. PubMed ID: 19384806
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of unilateral purple toes due to warfarin.
    Al-Niaimi F; Clark C
    Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
    [No Abstract]   [Full Text] [Related]  

  • 30. Washington's experience and recommendations Re: Anticoagulant rodenticides.
    Morrissey B; Burgess JL; Robertson WO
    Vet Hum Toxicol; 1995 Aug; 37(4):362-3. PubMed ID: 8540230
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 32. Images in cardiovascular medicine. Cholesterol embolization: unrecognized complication of thrombolysis.
    Pettelot G; Bracco J; Barrillon D; Baudouy M; Morand P
    Circulation; 1998 Apr; 97(15):1522. PubMed ID: 9576434
    [No Abstract]   [Full Text] [Related]  

  • 33. [Noscapine and warfarin--a potentially dangerous interaction].
    Myhr K
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540. PubMed ID: 19282895
    [No Abstract]   [Full Text] [Related]  

  • 34. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
    Genovesi S; Santoro A
    J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prothrombin complex concentrate important in warfarin induced hemorrhage].
    Holmström M
    Lakartidningen; 2009 Sep 9-15; 106(37):2270. PubMed ID: 19817159
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from the TAPS study - warfarin: a major cause of threats to patients safety.
    Lowthian J; Diug B
    Aust Fam Physician; 2008 Dec; 37(12):983. PubMed ID: 19156932
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible influence of atheroembolism in anticoagulant-related nephropathy: a nephrology image.
    Tanemoto M; Kimura T
    J Nephrol; 2023 Jan; 36(1):245-246. PubMed ID: 35226306
    [No Abstract]   [Full Text] [Related]  

  • 39. Diminutive gastrointestinal lesions in cholesterol crystal embolization.
    Hirahashi M; Matsumoto T; Esaki M; Nagata M; Hirakata H; Yao T; Iida M
    Endoscopy; 2005 Apr; 37(4):408. PubMed ID: 15824965
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application of warfarin pharmacogenetics].
    Vasků A
    Vnitr Lek; 2009 Jun; 55(6):541. PubMed ID: 19662883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.